Sara Teresa Méndez
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Sara Teresa Méndez has a total of 88 co-authors. Here are the top co-authors by number of shared publications:
- Horacio Reyes-Vivas
Laboratorio de Bioquímica-Genética, Instituto Nacional de Pediatría, Av. Insurgentes Sur No. 3700-C, Col. Insurgentes Cuicuilco, Alcaldía Coyoacán, Mexico City C.P. 04530, Mexico
11 shared publications - Jesús Oria-Hernández
Laboratorio de Bioquímica-Genética, Instituto Nacional de Pediatría, Insurgentes Sur 3700-C, Col. Insurgentes Cuicuilco, Alcaldía Coyoacán, Ciudad de Mexico 04530, Mexico
11 shared publications - Adriana Castillo-Villanueva
Laboratorio de Bioquímica-Genética, Instituto Nacional de Pediatría, Insurgentes Sur 3700-C, Col. Insurgentes Cuicuilco, Alcaldía Coyoacán, Ciudad de Mexico 04530, Mexico
9 shared publications Angélica Torres-Arroyo
Laboratorio de Bioquímica-Genética, Instituto Nacional de Pediatría. Insurgentes Sur 3700 Letra C, Av. Insurgentes Sur, Insurgentes Cuicuilco, Coyoacán. C.P. 04520, Ciudad de México, CDMX; Doctorado en Biología Experimental, División de Ciencias Biológicas y de la Salud, Universidad Autónoma Metropolitana Iztapalapa, Ciudad de México, CDMX
6 shared publications- Ignacio De la Mora-De la Mora
Laboratorio de Biomoléculas y Salud Infantil, Instituto Nacional de Pediatría, Secretaría de Salud, Mexico City 04530, Mexico
6 shared publications - Itzhel García-Torres
Laboratorio de Biomoléculas y Salud Infantil, Instituto Nacional de Pediatría, Mexico City 04530, Mexico
6 shared publications
Latest Publications
- Open Access
- 30 April 2026
- Published by Elsevier in Food and Chemical Toxicology
- Vol. 214, 116109
Physicochemical, structural, and immunological characterization of recombinant Mal d 1.02 allergen in Mexican pediatric patients. A valuable tool for diagnosing
- 30 April 2026
- Published by Elsevier in Food and Chemical Toxicology
- Vol. 214, 116109
Open AccessPhysicochemical, structural, and immunological characterization of recombinant Mal d 1.02 allergen in Mexican pediatric patients. A valuable tool for diagnosing
- Open Access
- 14 January 2022
- Published by Springer Nature in BMC Veterinary Research
- Vol. 18 (1) , 1-8
SAG3 Toxoplasma gondii cloning reveals unexpected fivefold infection in the blood of feral cats in the Mexican Caribbean
Background: Currently, more than 300 genotypes ofToxoplasma gondii(T. gondii)have been described throughout the world, demonstrating its wide genetic diversity. TheSAG3locus is one of the genes included in the genotyping panel of this parasite. It is associated with its virulence since it participates during the invasion process of the host cells. Therefore, cloning, sequencing, and bioinformatic analysis were used to deepen the understanding of theSAG3locus genetic diversity ofT. gondiiin blood samples from feral cats.Results: Six differentSAG3sequences were detected, five of which were detected in one feline. Three sequences were first reported here; one of them was an intragenic recombinant. In the cladogram, four out of tenSAG3sequences did not share nodes with others reported worldwide.Conclusions: Cloning and sequencing of samples with more than one restriction pattern by PCR-RFLP were very helpful tools to demonstrate the presence of more than three genotypes ofT. gondiiin the blood of feral cats from southeastern Mexico. This suggests a potential mixed infection of multipleT. gondiistrains and high genetic diversity of the parasites in felines in this tropical region of Mexico.
- 14 January 2022
- Published by Springer Nature in BMC Veterinary Research
- Vol. 18 (1) , 1-8
Open AccessSAG3 Toxoplasma gondii cloning reveals unexpected fivefold infection in the blood of feral cats in the Mexican Caribbean
Background: Currently, more than 300 genotypes ofToxoplasma gondii(T. gondii)have been described throughout the world, demonstrating its wide genetic diversity. TheSAG3locus is one of the genes included in the genotyping panel of this parasite. It is associated with its virulence since it participates during the invasion process of the host cells. Therefore, cloning, sequencing, and bioinformatic analysis were used to deepen the understanding of theSAG3locus genetic diversity ofT. gondiiin blood samples from feral cats.Results: Six differentSAG3sequences were detected, five of which were detected in one feline. Three sequences were first reported here; one of them was an intragenic recombinant. In the cladogram, four out of tenSAG3sequences did not share nodes with others reported worldwide.Conclusions: Cloning and sequencing of samples with more than one restriction pattern by PCR-RFLP were very helpful tools to demonstrate the presence of more than three genotypes ofT. gondiiin the blood of feral cats from southeastern Mexico. This suggests a potential mixed infection of multipleT. gondiistrains and high genetic diversity of the parasites in felines in this tropical region of Mexico.
- Open Access
- 19 December 2021
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 22 (24) , 13613
Benzimidazole Derivatives as New and Selective Inhibitors of Arginase from Leishmania mexicana with Biological Activity against Promastigotes and Amastigotes
Leishmaniasis is a disease caused by parasites of the Leishmania genus that affects 98 countries worldwide, 2 million of new cases occur each year and more than 350 million people are at risk. The use of the actual treatments is limited due to toxicity concerns and the apparition of resistance strains. Therefore, there is an urgent necessity to find new drugs for the treatment of this disease. In this context, enzymes from the polyamine biosynthesis pathway, such as arginase, have been considered a good target. In the present work, a chemical library of benzimidazole derivatives was studied performing computational, enzyme kinetics, biological activity, and cytotoxic effect characterization, as well as in silico ADME-Tox predictions, to find new inhibitors for arginase from Leishmania mexicana (LmARG). The results show that the two most potent inhibitors (compounds 1 and 2) have an I50 values of 52 μM and 82 μM, respectively. Moreover, assays with human arginase 1 (HsARG) show that both compounds are selective for LmARG. According to molecular dynamics simulation studies these inhibitors interact with important residues for enzyme catalysis. Biological activity assays demonstrate that both compounds have activity against promastigote and amastigote, and low cytotoxic effect in murine macrophages. Finally, in silico prediction of their ADME-Tox properties suggest that these inhibitors support the characteristics to be considered drug candidates. Altogether, the results reported in our study suggest that the benzimidazole derivatives are an excellent starting point for design new drugs against leishmanisis.
- 19 December 2021
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 22 (24) , 13613
Open AccessBenzimidazole Derivatives as New and Selective Inhibitors of Arginase from Leishmania mexicana with Biological Activity against Promastigotes and Amastigotes
Leishmaniasis is a disease caused by parasites of the Leishmania genus that affects 98 countries worldwide, 2 million of new cases occur each year and more than 350 million people are at risk. The use of the actual treatments is limited due to toxicity concerns and the apparition of resistance strains. Therefore, there is an urgent necessity to find new drugs for the treatment of this disease. In this context, enzymes from the polyamine biosynthesis pathway, such as arginase, have been considered a good target. In the present work, a chemical library of benzimidazole derivatives was studied performing computational, enzyme kinetics, biological activity, and cytotoxic effect characterization, as well as in silico ADME-Tox predictions, to find new inhibitors for arginase from Leishmania mexicana (LmARG). The results show that the two most potent inhibitors (compounds 1 and 2) have an I50 values of 52 μM and 82 μM, respectively. Moreover, assays with human arginase 1 (HsARG) show that both compounds are selective for LmARG. According to molecular dynamics simulation studies these inhibitors interact with important residues for enzyme catalysis. Biological activity assays demonstrate that both compounds have activity against promastigote and amastigote, and low cytotoxic effect in murine macrophages. Finally, in silico prediction of their ADME-Tox properties suggest that these inhibitors support the characteristics to be considered drug candidates. Altogether, the results reported in our study suggest that the benzimidazole derivatives are an excellent starting point for design new drugs against leishmanisis.
- 6 March 2019
- Published by Elsevier in Acta Tropica
- Vol. 193, 199-205
Mixed Toxoplasma gondii infection and new genotypes in feral cats of Quintana Roo, México
- 6 March 2019
- Published by Elsevier in Acta Tropica
- Vol. 193, 199-205
Mixed Toxoplasma gondii infection and new genotypes in feral cats of Quintana Roo, México
- Open Access
- 1 December 2017
- Published by Elsevier in International Journal for Parasitology: Drugs and Drug Resistance
- Vol. 7 (3) , 425-432
Disulfiram as a novel inactivator of Giardia lamblia triosephosphate isomerase with antigiardial potential
- 1 December 2017
- Published by Elsevier in International Journal for Parasitology: Drugs and Drug Resistance
- Vol. 7 (3) , 425-432
Open AccessDisulfiram as a novel inactivator of Giardia lamblia triosephosphate isomerase with antigiardial potential
- Open Access
- 10 August 2017
- Published by Springer Nature in Scientific Reports
- Vol. 7 (1) , 1-14
Novel giardicidal compounds bearing proton pump inhibitor scaffold proceeding through triosephosphate isomerase inactivation
Giardiasis is a worldwide parasitic disease that affects mainly children and immunosuppressed people. Side effects and the emergence of resistance over current used drugs make imperative looking for new antiparasitics through discovering of new biological targets and designing of novel drugs. Recently, it has determined that gastric proton-pump inhibitors (PPI) have anti-giardiasic activity. The glycolytic enzyme, triosephosphate isomerase (GlTIM), is one of its potential targets. Therefore, we employed the scaffold of PPI to design new compounds aimed to increase their antigiardial capacity by inactivating GlTIM. Here we demonstrated that two novel PPI-derivatives (BHO2 and BHO3), have better anti-giardiasic activity than omeprazole in concentrations around 120–130 µM, without cytotoxic effect on mammal cell cultures. The derivatives inactivated GlTIM through the chemical modification of Cys222 promoting local structural changes in the enzyme. Furthermore, derivatives forms adducts linked to Cys residues through a C-S bond. We demonstrated that PPI can be used as scaffolds to design better antiparasitic molecules; we also are proposing a molecular mechanism of reaction for these novel derivatives.
- 10 August 2017
- Published by Springer Nature in Scientific Reports
- Vol. 7 (1) , 1-14
Open AccessNovel giardicidal compounds bearing proton pump inhibitor scaffold proceeding through triosephosphate isomerase inactivation
Giardiasis is a worldwide parasitic disease that affects mainly children and immunosuppressed people. Side effects and the emergence of resistance over current used drugs make imperative looking for new antiparasitics through discovering of new biological targets and designing of novel drugs. Recently, it has determined that gastric proton-pump inhibitors (PPI) have anti-giardiasic activity. The glycolytic enzyme, triosephosphate isomerase (GlTIM), is one of its potential targets. Therefore, we employed the scaffold of PPI to design new compounds aimed to increase their antigiardial capacity by inactivating GlTIM. Here we demonstrated that two novel PPI-derivatives (BHO2 and BHO3), have better anti-giardiasic activity than omeprazole in concentrations around 120–130 µM, without cytotoxic effect on mammal cell cultures. The derivatives inactivated GlTIM through the chemical modification of Cys222 promoting local structural changes in the enzyme. Furthermore, derivatives forms adducts linked to Cys residues through a C-S bond. We demonstrated that PPI can be used as scaffolds to design better antiparasitic molecules; we also are proposing a molecular mechanism of reaction for these novel derivatives.
- Open Access
- 1 May 2017
- Published by Elsevier in Boletín Médico del Hospital Infantil de México
- Vol. 74 (3) , 233-240
Proteomics: a tool to develop novel diagnostic methods and unravel molecular mechanisms of pediatric diseases
- 1 May 2017
- Published by Elsevier in Boletín Médico del Hospital Infantil de México
- Vol. 74 (3) , 233-240
Open AccessProteomics: a tool to develop novel diagnostic methods and unravel molecular mechanisms of pediatric diseases
- 19 December 2015
- Published by Springer Nature in The Protein Journal
- Vol. 35 (1) , 24-33
Cloning, Expression and Characterization of Recombinant, NADH Oxidase from Giardia lamblia
The NADH oxidase family of enzymes catalyzes the oxidation of NADH by reducing molecular O2 to H2O2, H2O or both. In the protozoan parasite Giardia lamblia, the NADH oxidase enzyme (GlNOX) produces H2O as end product without production of H2O2. GlNOX has been implicated in the parasite metabolism, the intracellular redox regulation and the resistance to drugs currently used against giardiasis; therefore, it is an interesting protein from diverse perspectives. In this work, the GlNOX gene was amplified from genomic G. lamblia DNA and expressed in Escherichia coli as a His-Tagged protein; then, the enzyme was purified by immobilized metal affinity chromatography, characterized, and its properties compared with those of the endogenous enzyme previously isolated from trophozoites (Brown et al. in Eur J Biochem 241(1):155–161, 1996). In comparison with the trophozoite-extracted enzyme, which was scarce and unstable, the recombinant heterologous expression system and one-step purification method produce a stable protein preparation with high yield and purity. The recombinant enzyme mostly resembles the endogenous protein; where differences were found, these were attributable to methodological discrepancies or artifacts. This homogenous, pure and functional protein preparation can be used for detailed structural or functional studies of GlNOX, which will provide a deeper understanding of the biology and pathogeny of G. lamblia.
- 19 December 2015
- Published by Springer Nature in The Protein Journal
- Vol. 35 (1) , 24-33
Cloning, Expression and Characterization of Recombinant, NADH Oxidase from Giardia lamblia
The NADH oxidase family of enzymes catalyzes the oxidation of NADH by reducing molecular O2 to H2O2, H2O or both. In the protozoan parasite Giardia lamblia, the NADH oxidase enzyme (GlNOX) produces H2O as end product without production of H2O2. GlNOX has been implicated in the parasite metabolism, the intracellular redox regulation and the resistance to drugs currently used against giardiasis; therefore, it is an interesting protein from diverse perspectives. In this work, the GlNOX gene was amplified from genomic G. lamblia DNA and expressed in Escherichia coli as a His-Tagged protein; then, the enzyme was purified by immobilized metal affinity chromatography, characterized, and its properties compared with those of the endogenous enzyme previously isolated from trophozoites (Brown et al. in Eur J Biochem 241(1):155–161, 1996). In comparison with the trophozoite-extracted enzyme, which was scarce and unstable, the recombinant heterologous expression system and one-step purification method produce a stable protein preparation with high yield and purity. The recombinant enzyme mostly resembles the endogenous protein; where differences were found, these were attributable to methodological discrepancies or artifacts. This homogenous, pure and functional protein preparation can be used for detailed structural or functional studies of GlNOX, which will provide a deeper understanding of the biology and pathogeny of G. lamblia.
- 1 December 2015
- Published by Springer Nature in Molecular & Cellular Toxicology
- Vol. 11 (4) , 407-414
Analysis of Cyp2b1 gene expression in the rat liver and brain by multiplex PCR
- 1 December 2015
- Published by Springer Nature in Molecular & Cellular Toxicology
- Vol. 11 (4) , 407-414
Analysis of Cyp2b1 gene expression in the rat liver and brain by multiplex PCR
- 1 May 2015
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 23 (9) , 2204-2210
Synthesis of nitro(benzo)thiazole acetamides and in vitro antiprotozoal effect against amitochondriate parasites Giardia intestinalis and Trichomonas vaginalis
- 1 May 2015
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 23 (9) , 2204-2210
Synthesis of nitro(benzo)thiazole acetamides and in vitro antiprotozoal effect against amitochondriate parasites Giardia intestinalis and Trichomonas vaginalis